Preparation and Mechanism of the Antitumor Action of a 4H-Aminochromene Compound

E. A. Samyshina, K. K. Arutyunyan(Sechenov University), Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Yu. A. Shifrin(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), E. V. Blinova(Sechenov University), A. A. Makhrova(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), E. A. Simakina, О. М. Тумутолова(National Research Mordovia State University), D. N. Shimanovskii(Sechenov University), А. А. Епишкина(Sechenov University), M. Yu. Kudryavtsev(Sechenov University), E. V. Shilova, O. N. Deryabina(National Research Mordovia State University), S. Ya. Skachilova
Pharmaceutical Chemistry Journal
March 30, 2022
10.1007/s11094-022-02593-3
Cited by 0

Related Papers

Patient-Derived Non-Muscular Invasive Bladder Cancer Xenografts of Main Molecular Subtypes of the Tumor for Anti-Pd-l1 Treatment Assessment
|Cells|2019|19
Novel Hydroxypyridine Compound Protects Brain Cells against Ischemic Damage In Vitro and In Vivo
|International Journal of Molecular Sciences|2022|16
Novel aminochromone derivative inhibits tumor growth on xenograft model of lung cancer in mice
|Journal of Advanced Pharmaceutical Technology amp Research|2018|14
Prognostic Role of FGFR3 Expression Status and Tumor-Related MicroRNAs Level in Association with PD-L1 Expression in Primary Luminal Non-Muscular Invasive Bladder Carcinoma
|Life|2020|13
Anticancer signal transduction pathways of selenium nanoparticles in mouse colorectal cancer model
|Biochemical and Biophysical Research Communications|2025|12